NCT02078440 - Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Type 2 Diabetes

Interventions

DRUG

Bromocriptine mesylate

Cycloset (bromocriptine mesylate quick release) 0.8 mg tablets, weight adjusted 1.6 mg- 4.8 mg

Trial Locations (5)

Children's Hosptial of Philadelphia, Philadelphia

Columbus Clinical Services LLC, Miami

The Children's Mercy Hospital, Kansas City

Hope Research Institute, Llc, Phoenix

Yale Center for Clinical Investigation, New Haven